HMGB1 and metabolic dysfunction-associated steatotic liver disease: In animal models of NAFLD, HFD increases the accumulation of triglycerides and free fatty acids, and increases the expression of HMGB1 and lipogenesis gene (SREBP-2) in the liver, which is attenuated by the application of Ecklonia cava extract [30].